Pharmaceutical

Q1 earnings pulse check: companies tentative on pharma-specific tariffs

Whilst 2025 outlooks include cost impact from existing tariffs, companies have not adjusted their guidance for future pharma-specific ones.

May 4, 2025 - 06:00
Q1 earnings pulse check: companies tentative on pharma-specific tariffs
Whilst 2025 outlooks include cost impact from existing tariffs, companies have not adjusted their guidance for future pharma-specific ones.
Read the original article

Tags:

Previous Article

Pliant cuts workforce by 45% following lung trial termination 

Next Article

MHRA authorises Bavarian Nordic’s chikungunya virus vaccine

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Wane in Covid demand hurts Walgreens as profits drop to $118m

Wane in Covid demand hurts Walgreens as profits drop to...

Jun 27, 2023

STAT+: Listen: Is the Nobel committee evolving? Plus, preventing public health’s wiliest virus

STAT+: Listen: Is the Nobel committee evolving? Plus, p...

Oct 8, 2023

Tired of ‘dead end’ approach, herpes patients mobilize to demand government action

Tired of ‘dead end’ approach, herpes patients mobilize ...

Apr 21, 2023